Medicine
AssigneeKowa Company, Ltd.
InventorChisa NISHIDA
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical product which includes a solid preparation comprising pitavastatin or a salt thereof, in which production of a lactone form thereof is suppressed. The pharmaceutical product is characterized by including a solid preparation comprising the following ingredients (A) and (B): (A) pitavastatin or a salt thereof; and (B) at least one member selected from the group consisting of carmellose and a salt thereof, crospovidone, and microcrystalline cellulose, and the solid preparation having a water content of 2.9 mass % or less, wherein the solid preparation is stored in a tight package.
Claims11
A pharmaceutical product, comprising:
- a solid preparation comprising ingredients (A) and (B):
- (A) pitavastatin or a salt thereof;
- and
- (B) at least one hygroscopic pharmaceutically acceptable additive,
- wherein the solid preparation has a water content of 2.9 mass % or less, and is stored in a tight package.
A solid preparation, comprising:
- (A) pitavastatin or a salt thereof;
- and
- (B) at least one hygroscopic pharmaceutically acceptable additive,
- wherein the solid preparation has a water content of 2.9 mass % or less.
Dependencies are inferred from the claim text.